1. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349(6):58396. doi:10.1056/NEJMra023144.
2. Masri A, Bukhari S, Eisele YS, Soman P. Molecular Imaging of Cardiac Amyloidosis. J Nucl Med. 2020;61(7):965-70. doi:10.2967/jnumed.120.245381.
3. Kyle RA, Larson DR, Therneau TM, et al. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance. N Engl J Med. 2018;378(3):241-9. doi:10.1056/NEJMoa1709974.
4. Zampieri M, Nardi G, Del Monaco G, et al. Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany. Int J Cardiol. 2021;335:123-7. doi:10.1016/j.ijcard.2021.04.023.
5. Насонова С. Н., Жиров И. В., Шошина А. А. и др. Экспертный центр по амилоидозу сердца: реалии и перспективы. Терапевтический архив. 2024;96(4):321-9. doi:10.26442/00403660.2024.04.202677.
6. Cipriani A, De Michieli L, Porcari A, et al. Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value. JACC CardioOncol. 2022;4(4):458-70. doi:10.1016/j.jaccao.2022.08.007.
7. Cyrille NB, Goldsmith J, Alvarez J, et al. Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis. Am J Cardiol. 2014;114(7):1089-93. doi:10.1016/j.amjcard.2014.07.026.
8. Murtagh B, Hammill SC, Gertz MA, et al. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol. 2005;95(4):5357. doi:10.1016/j.amjcard.2004.10.028.
9. Chao CJ, Jeong J, Arsanjani R, et al. Echocardiography-Based Deep Learning Model to Differentiate Constrictive Pericarditis and Restrictive Cardiomyopathy. JACC Cardiovasc Imaging. 2024;17(4):349-60. doi:10.1016/j.jcmg.2023.09.011.
10. Jeong J, Chao CJ, Arsanjani R, et al. Challenges and solutions of echocardiography generalization for deep learning: a study in patients with constrictive pericarditis. J Med Imaging (Bellingham). 2023;10(5):054502. doi:10.1117/1.JMI.10.5.054502.
11. Grogan M, Lopez-Jimenez F, Guthrie S, et al. Value of Artificial Intelligence for Enhancing Suspicion of Cardiac Amyloidosis Using Electrocardiography and Echocardiography: A Narrative Review. J Am Heart Assoc. 2025;14(8):e036533. doi:10.1161/JAHA.124.036533.
12. Grogan M, Lopez-Jimenez F, Cohen‐Shelly M, et al. Artificial Intelligence-Enhanced Electrocardiogram for the Early Detection of Cardiac Amyloidosis. Mayo Clin Proc. 2021;96(11):2768-78. doi:10.1016/j.mayocp.2021.04.023.
13. Haimovich JS, Diamant N, Khurshid S, et al. Artificial intelligence-enabled classification of hypertrophic heart diseases using electrocardiograms. Cardiovasc Digit Health J. 2023;4(2):48-59. doi:10.1016/j.cvdhj.2023.03.001.
14. Harmon DM, Mangold K, Baez Suarez A, et al. Postdevelopment Performance and Validation of the Artificial Intelligence-Enhanced Electrocardiogram for Detection of Cardiac Amyloidosis. JACC: Advances. 2023;2(8):100612. doi:10.1016/j.jacadv.2023.100612.
15. Schrutka L, Anner P, Agibetov A, et al. Machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosis. Heart. 2022;108(14):1137-47. doi:10.1136/heartjnl-2021-319846.
16. Khan LA, Shaikh FH, Khan MS, et al. Artificial intelligence-enhanced electrocardiogram for the diagnosis of cardiac amyloidosis: A systemic review and meta-analysis. Curr Probl Cardiol. 2024;49(12):102860. doi:10.1016/j.cpcardiol.2024.102860.
17. Mahabadi AA, Knobeloch J, Backmann V, et al. Novel three-dimensional ECG algorithm for reliable screening for cardiac amyloidosis. ESC Heart Fail. 2025;12(4):2993-3002. doi:10.1002/ehf2.15318.
18. Дроздов Д. В., Сахнова Т. А., Блинова Е. В. и др. Основы вычислительной векторэлектрокардиографии и ее практическое применение: учебно-методическое пособие. Москва: ГЭОТАР МЕДИА, 2026. 176 с. ISBN: 978-5-9704-9705-0. doi:10.33029/9704-9705-0-FCV-2026-1-176. EDN: LJDKCE.
19. Martini N, Sinigiani G, De Michieli L, et al. Electrocardiographic features and rhythm disorders in cardiac amyloidosis. Trends Cardiovasc Med. 2024;34(4):257-64. doi:10.1016/j. tcm.2023.02.006.
20. Ng PLF, Lim YC, Evangelista LKM, et al. Utility and pitfalls of the electrocardiogram in the evaluation of cardiac amyloidosis. Ann Noninvasive Electrocardiol. 2022;27(4):e12967. doi:10.1111/anec.12967.